The full name of Gemeixing is Gemeixing Cell Light. Gemeixing Cell Light was approved by CFDA in China in 2014. In the same year, joint clinical demonstrations at four major hospitals were completed at the Seventh Medical Center of the People's Liberation Army in Beijing, Guangzhou Southern Theater General Hospital, Huashan Hospital Affiliated to Fudan University in Shanghai, and Xijing Hospital in Xi'an, proving that the innovative technology of fractional IPL can effectively treat chloasma. During the management process, the common side effects of IPL such as burns and blackening can be greatly reduced. The clinical usability is greatly improved.

Refer to Baidu Others